Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Hepatitis B Vaccines
1. 104504-34-9
2. Hepatitis B Vaccines
3. Vaccine, Hepatitis B
4. Vaccines, Hepatitis B
5. Refchem:922839
6. Recombinant Hepatitis B Vaccine
7. Heplisav
8. Hepatitis B Virus Pre-s Region (120-145)
9. Schembl29370117
10. Da-53942
11. Hepatitus B Virus Pre-s Region (120-145)
12. Glycine, L-methionyl-l-glutaminyl-l-tryptophyl-l-asparaginyl-l-seryl-l-threonyl-l-threonyl-l-phenylalanyl-l-histidyl-l-glutaminyl-l-threonyl-l-leucyl-l-glutaminyl-l-.alpha.-aspartyl-l-prolyl-l-arginyl-l-valyl-l-arginylglycyl-l-leucyl-l-tyrosyl-l-phenylalanyl-l-prolyl-l-alanylglycyl-
| Molecular Weight | 3008.3 g/mol |
|---|---|
| Molecular Formula | C135H199N39O38S |
| XLogP3 | -10.8 |
| Hydrogen Bond Donor Count | 41 |
| Hydrogen Bond Acceptor Count | 44 |
| Rotatable Bond Count | 95 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 1280 |
| Heavy Atom Count | 213 |
| Formal Charge | 0 |
| Complexity | 7120 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 26 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Prevention of hepatitis B virus infection
Indicated for active immunisation of adults against hepatitis B virus (HBV) infection
Public health officials have ranked the reduction in vaccine-preventable diseases as one of the top 10 public health achievements in the 21 century. The hepatitis B vaccine is an integral part of this achievement, and its role continues to evolve this century. Hepatitis B vaccination is indicated to prevent active infection with the hepatitis B virus, which can lead to chronic liver failure and hepatocellular carcinoma. The virus is highly infectious and can transmit through percutaneous or mucosal exposure to blood and body fluids. The virus even remains viable on environmental surfaces for more than seven days.
ATC: J07BC01
J07BC01
ABOUT THIS PAGE